SCHEMBL4504149

SCHEMBL4504149

CN1CCN(C(=O)c2ccc(N/C(=C3\C(=O)Nc4cc(Cl)ccc43)c3ccc(N)c([N+](=O)[O-])c3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PIM1 P11309 4/20 0.39
PIM2 Q9P1W9 4/20 0.39
KMT2A Q03164 3/20 0.38
HTT P42858 2/20 0.38
EPHX2 P34913 1/20 0.38
HPGD P15428 1/20 0.38
RECQL P46063 1/20 0.38
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37
PDGFRB P09619 1/20 0.37
SRC P12931 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
MEN1 O00255 1/20 0.37
MITF O75030 1/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
ABL1 P00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3933915 1.00 SMN1; SMN2 (0.41) SMN1; SMN2POLBL3MBTL1PIM1PIM2
SCHEMBL3933922 1.00 SMN1; SMN2 (0.41) SMN1; SMN2POLBL3MBTL1PIM1PIM2
SCHEMBL4478442 0.90 L3MBTL1 (0.45) SMN1; SMN2POLBL3MBTL1PIM1PIM2
SCHEMBL4478443 0.90 L3MBTL1 (0.45) SMN1; SMN2POLBL3MBTL1PIM1PIM2
SCHEMBL3938708 0.89 POLB (0.45) POLBPIM1PIM2KMT2AEPHX2
SCHEMBL3938711 0.89 POLB (0.45) POLBPIM1PIM2KMT2AEPHX2
SCHEMBL4498298 0.86 POLB (0.46) POLBPIM1PIM2KMT2AEPHX2
SCHEMBL4498302 0.86 POLB (0.46) POLBPIM1PIM2KMT2AEPHX2
SCHEMBL4485376 0.83 ALDH1A1 (0.44) L3MBTL1KMT2AHTTMAPTALDH1A1
SCHEMBL3937661 0.83 ALDH1A1 (0.44) L3MBTL1KMT2AHTTMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR SMN1; SMN2 4006/4885POLB 4146/4885L3MBTL1 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.